Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 858 to 907 of 3730 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Filtered\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vinexin (sh3-containing adaptor molecule-1) (scam-1). [source:swissprot;acc:o60504]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6272.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7226.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15195\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
430\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial precursor (ec 1.3.5.1) (fp) (flavoprotein subunit of complex ii). [source:swissprot;acc:p31040]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10247.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10535\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02803\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-2 (e2f dimerization partner 2). [source:swissprot;acc:q14188]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3804.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4379.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15123\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
431\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3849.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4431.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15102\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nascent-polypeptide-associated complex alpha polypeptide. [source:refseq;acc:nm\_005594]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
146.622\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
150.709\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02787\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
432\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
high-glucose-regulated protein 8 (ny-ren-2 antigen). [source:swissprot;acc:q9y5a9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
100.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
103.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02736\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial processing peptidase beta subunit, mitochondrial precursor (ec 3.4.24.64) (beta-mpp) (p-52). [source:swissprot;acc:o75439]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5244.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6036.27\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15093\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
433\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5244.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6036.38\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15091\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sh3 adapter protein spin90 (sh3 protein interacting with nck, 90 kda) (vaca-interacting protein, 54 kda) (vip54) (af3p21) (diaphanous protein interacting protein) (dia interacting protein-1) (dip-1). [source:swissprot;acc:q9nzq3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
100.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
103.25\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02736\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
434\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
testis-specific protein tpx-1 precursor (cysteine-rich secretory protein-2) (crisp-2). [source:swissprot;acc:p16562]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
201\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.5\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase complex core protein i, mitochondrial precursor (ec 1.10.2.2). [source:swissprot;acc:p31930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5246.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6037.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15077\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
435\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elav-like protein 3 (hu-antigen c) (huc) (paraneoplastic cerebellar degeneration-associated antigen) (paraneoplastic limbic encephalitis antigen 21). [source:swissprot;acc:q14576]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5891.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5737.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02677\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
proline synthetase co-transcribed bacterial homolog protein. [source:swissprot;acc:o94903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5233.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6022.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1507\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
436\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha-nac protein. [source:sptrembl;acc:q9h009]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
147.221\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
151.122\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0265\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6230.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7168.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15042\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
437\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-140 (protein ptd008) (my006 protein). [source:swissprot;acc:q9y284]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2331\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2390\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02531\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of swi4 1 homolog (ssf-1) (peter pan homolog). [source:swissprot;acc:q9nq55]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3779.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4348.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15042\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
438\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
3-hydroxyisobutyryl-coenzyme a hydrolase. [source:refseq;acc:nm\_014362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2925.57\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2853.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0252\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related, matrix-associated, actin-dependent regulator of chromatin subfamily f member 1 (swi-snf complex protein p270) (b120). [source:swissprot;acc:o14497]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6252.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7192.88\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.15039\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
439\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein c20orf45 (cgi-107). [source:swissprot;acc:q9y3b1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
532.667\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
546\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02503\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
440\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.08\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
limbic system-associated membrane protein precursor (lsamp). [source:swissprot;acc:q13449]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6830.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7000.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02491\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
441\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartate beta-hydroxylase isoform b; junctin isoform 1; junctate; aspartyl/asparaginyl-beta-hydroxylase; peptide-aspartate beta-dioxygenase; humbug. [source:refseq;acc:nm\_032468]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6158\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02355\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
grancalcin. [source:swissprot;acc:p28676]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
442\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
repressor of estrogen receptor activity; b-cell associated protein. [source:refseq;acc:nm\_007273]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6699.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6856.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02335\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.17\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6252.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7192.51\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ribosomal protein s27-like protein; 40s ribosomal protein s27 isoform. [source:refseq;acc:nm\_015920]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
2432.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2379.52\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02223\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s27 (metallopan-stimulin 1) (mps-1). [source:swissprot;acc:p42677]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
2431.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2378.99\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
probable rrna processing protein ebp2 (ebna1 binding protein 2) (nucleolar protein p40). [source:swissprot;acc:q99848]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3758.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4322.87\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.15011\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ad24 protein. [source:refseq;acc:nm\_022451]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
3753.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4315.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14978\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mstp028 protein. [source:refseq;acc:nm\_031954]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
9988.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
9808.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01835\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
mevalonate kinase (ec 2.7.1.36) (mk). [source:swissprot;acc:q03426]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
1549.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1522.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01787\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3766.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4329.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14958\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s3a. [source:swissprot;acc:p49241]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2929.51\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2879.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01735\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
3751.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4310.89\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14922\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6259.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7190.91\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14884\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein disulfide isomerase precursor (pdi) (ec 5.3.4.1) (prolyl 4- hydroxylase beta subunit) (cellular thyroid hormone binding protein) (p55). [source:swissprot;acc:p07237]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
524.415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
533.236\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01682\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
segment polarity protein dishevelled homolog dvl-1 (dishevelled-1) (dsh homolog 1). [source:swissprot;acc:o14640]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
5699.32\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5607.7\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01634\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 12 (ytm1 homolog). [source:swissprot;acc:q9gzl7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3761.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4319.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14837\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj153g14.2 (possible ca binding protein similar to nefa) (fragment). [source:sptrembl;acc:q9ujn8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4158.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4094.09\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01569\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4889.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14753\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
451\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 10 (26s proteasome regulatory subunit p28) (gankyrin). [source:swissprot;acc:o75832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2683.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2642.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01545\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
n-myc proto-oncogene protein. [source:swissprot;acc:p04198]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4889.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5610.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14745\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
452\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanine aminotransferase (ec 2.6.1.2) (glutamic--pyruvic transaminase) (gpt) (glutamic--alanine transaminase). [source:swissprot;acc:p24298]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1527.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1504.85\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01496\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3760.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4315.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.14738\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
453\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1337.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1356.52\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01438\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3760.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
4315.06\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.14738\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/